Abstract
Purpose
To explore the regulatory effect of let-7a-5p/TGFBR1/Smad3 on the proliferation activity of cervical cancer cells.
Methods
The difference in let-7a-5p expression between normal people and patients with cervical cancer was detected by miREIA assay. The differences of let-7a-5p expression between cervical cancer cell line C33a and adjacent normal epithelial cell line HUCEC were determined by qRT-PCR.
Results
miREIA result showed that let-7a-5p concentrations were 178.5 ± 24.3 μg/L in healthy individuals and 106.1 ± 14.8 μg/L in cervical cancer patients (P = 0.0002). qRT-PCR showed that let-7a-5p in cervical cancer tissue (0.57 ± 0.03) was lower than that in adjacent normal tissue (0.84 ± 0.04, P = 0.0107). Compared with normal cervical epithelial cells (HUCEC), the expression of let-7a-5p was lower in cervical cancer cells (C33a, Hela, P = 0.0001). The results of CCK-8 and EDU detection showed that activation of let-7a-5p inhibited the proliferation of C33a (P = 0.00130, P << 0.0001) and Hela (P = 0.00254, P = 0.0066) cells. According to the analysis using Starbase V2.0 online database, let-7a-5p could target TGFβR1 in cervical cancer cell lines, and the let-7a-5p mimic reduces the mRNA expression level of TGFβR1 in cervical cancer cell C33a (P = 0.0067). Western blot results showed that TGFBR1 expression significantly decreased in cervical cancer cells after let-7a-5p mimic treatment (P = 0.0048) and significantly increased after let-7a-5p mimic inhibitor treatment (P = 0.0003).
Conclusions
let-7a-5p represents the independent novel anti-oncogenes in cervical cancer, which can regulate TGF-β1/TGFBR1/pSmad3 cell pathway and interfere with the proliferation of cervical cancer cells. Therefore, let-7a-5p can serve as a novel potential therapeutic target for the treatment of cervical cancer.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Change history
07 July 2022
A Correction to this paper has been published: https://doi.org/10.1007/s12094-022-02878-9
References
Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393:169–82.
Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7:5217–36.
Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Res. 2019;8:100170.
Johnson CA, James D, Marzan A, et al. Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs. 2019;35:166–74.
Kessler TA. Cervical cancer: prevention and early detection. Semin Oncol Nurs. 2017;33:172–83.
Buruiana A, Florian SI, Florian AI, et al. The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21061950.
Chuderland D, Marmor G, Shainskaya A, et al. Calcium-mediated interactions regulate the subcellular localization of extracellular signal-regulated kinases (ERKs). Cell Physiol Biochem. 2020;54:474–92.
Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
Rao AM, Quddusi A, Shamim MS. The significance of MGMT methylation in glioblastoma multiforme prognosis. J Pak Med Assoc. 2018;68:1137–9.
Tiwari A, Mukherjee B, Dixit M. MicroRNA key to angiogenesis regulation: MiRNA biology and therapy. Curr Cancer Drug Targets. 2018;18:266–77.
Hrovatin K, Kunej T. Classification of miRNA-related sequence variations. Epigenomics. 2018;10:463–81.
Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ action through miRNA editing. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20246249.
Duan S, Yu S, Yuan T, et al. Exogenous Let-7a-5p induces A549 lung cancer cell death through BCL2L1-mediated PI3Kγ signaling pathway. Front Oncol. 2019;9:808.
Ma W, Dou Q, Ha X. Let-7a-5p inhibits BMSCs osteogenesis in postmenopausal osteoporosis mice. Biochem Biophys Res Commun. 2019;510:53–8.
Wang WT, Zhao YN, Yan JX, et al. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol. 2014;7:6.
Lee TH, Yeh CF, Lee YT, et al. Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization. Nat Comm. 2020;11:4254.
Li H, Wu X, Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016;27:e43.
Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71:313–20.
Vu M, Yu J, Awolude OA, et al. Cervical cancer worldwide. Curr Probl Cancer. 2018;42:457–65.
Olusola P, Banerjee HN, Philley JV, et al. Human papilloma virus-associated cervical cancer and health disparities. Cells. 2019. https://doi.org/10.3390/cells8060622.
Wu W, Yu T, Wu Y, et al. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression. J Exp Clin Cancer Res. 2019;38:133.
Zhang JX, He WL, Feng ZH, et al. A positive feedback loop consisting of C12orf59/NF-kappaB/CDH11 promotes gastric cancer invasion and metastasis. J Exp Clin Cancer Res. 2019;38:164.
Chen C, Liu X, Chen C, et al. Clinical significance of let-7a-5p and miR-21-5p in patients with breast cancer. Ann Clin Lab Sci. 2019;49:302–8.
Duan S, Yu S, Yuan T, et al. Exogenous Let-7a-5p induces A549 lung cancer cell death through BCL2L1-mediated PI3Kgamma signaling pathway. Front Oncol. 2019;9:808.
Liu L, Zhao J, Peng Y, et al. miR-let-7a-5p Inhibits Invasion and migration of hepatoma cells by regulating BZW2 expression. Onco Targets Ther. 2020;13:12269–79.
Bai T, Liu Y, Li B. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. IUBMB Life. 2019;71:1537–51.
Duan S, Li J, Tian J, et al. Crosstalk between let-7a-5p and BCL-xL in the initiation of toxic autophagy in lung cancer. Mol Ther Oncolytics. 2019;15:69–78.
Li J, Tang Q, Dong W, et al. CircBACH1/let-7a-5p axis enhances the proliferation and metastasis of colorectal cancer by upregulating CREB5 expression. J Gastrointest Oncol. 2020;11:1186–99.
Li JP, Liao XH, Xiang Y, et al. Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest. Gene. 2018;679:232–40.
Funding
This study was funded by General Project of Fujian Natural Science Foundation (2017J01254) and Joint Fund Project of Provincial Science and Technology Innovation, 2020 (No. 2020Y9153).
Author information
Authors and Affiliations
Contributions
ZC and HS conceived and designed the study, and drafted the manuscript. ZC, JQ, YG, QL and YL collected, analyzed and interpreted the experimental data. JQ and HS revised the manuscript for important intellectual content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no financial conflicts of interest.
Ethical approval
Written informed consent was obtained from patients with approval by the Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital.
Consent to participate
Written informed consent was obtained from patients with approval by the Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised to include the equal contribution statement of authors.
Rights and permissions
About this article
Cite this article
Chen, Z., Qiu, J., Gao, Y. et al. Study on the mechanism of let-7a-5p in regulating the proliferation in cervical cancer cells. Clin Transl Oncol 24, 1631–1642 (2022). https://doi.org/10.1007/s12094-022-02810-1
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s12094-022-02810-1